Document:

<PAGE>

                                                                   EXHIBIT 10.10
                                                                 GRANT NO.______

                           IMPAC MEDICAL SYSTEMS, INC.

                                 2002 STOCK PLAN

                       NONSTATUTORY STOCK OPTION AGREEMENT

         IMPAC Medical Systems, Inc. (the "Company"), hereby grants an Option to
purchase shares of its common stock (the "Shares") to the Optionee named below.
The terms and conditions of the Option are set forth in this cover sheet, in the
attachment and in the Company's 2002 Stock Plan (the "Plan").

Date of Option Grant:  __________________, 200__

Name of Optionee:  _________________________________________________

Number of Shares Covered by Option:  ______________

Exercise Price per Share:  $_____.___

Total Exercise Price:  $_____.__

Vesting Start Date:  _____________, 200__

Vesting Schedule:

         Subject to all the terms of the attached Agreement, your right to
purchase Shares under this Option vests as to one-fourth (1/4) of the total
number of Shares covered by this Option, as shown above, on the one-year
anniversary of the Vesting Start Date. Thereafter, the number of Shares which
you may purchase under this Option shall vest at the rate of one-forty-eighth
(1/48) per month on the 1st day of each of the thirty-six (36) months following
the month of the one-year anniversary of the Vesting Start Date. The resulting
aggregate number of vested Shares will be rounded to the nearest whole number.
No additional Shares will vest after your Service has terminated for any reason.

         By signing this cover sheet, you agree to all of the terms and
conditions described in the attached Agreement and in the Plan, a copy of which
is also enclosed.

Optionee     _____________________________________________________
                                 (Signature)

Company:     _____________________________________________________
                                 (Signature)

             Title:  _____________________________________________

Attachment
----------

<PAGE>

                           IMPAC MEDICAL SYSTEMS, INC.

                                 2002 STOCK PLAN

                       NONSTATUTORY STOCK OPTION AGREEMENT

The Plan and                  The text of the Plan is incorporated in this
Other Agreements              Agreement by reference. Certain capitalized terms
                              used in this Agreement are defined in the Plan.

                              This Agreement and the Plan constitute the entire
                              understanding between you and the Company
                              regarding this Option. Any prior agreements,
                              commitments or negotiations concerning this Option
                              are superseded.

Nonstatutory Stock Option     This Option is not intended to be an Incentive
                              Stock Option under section 422 of the Internal
                              Revenue Code and will be interpreted accordingly.

Vesting                       This Option is only exercisable before it expires
                              and then only with respect to the vested portion
                              of the Option. This Option will vest according to
                              the Vesting Schedule on the attached cover sheet.

Term                          Your Option will expire in any event at the close
                              of business at Company headquarters on the day
                              before the 10th anniversary of the Date of Option
                              Grant, as shown on the cover sheet. Your Option
                              will expire earlier if your Service terminates, as
                              described below.

Regular Termination           If your Service terminates for any reason, other
                              than death, Disability or Cause, as defined below,
                              then your Option will expire at the close of
                              business at Company headquarters on the 90th day
                              after your termination date.

Termination for               If your Service is terminated for Cause, as
Cause                         determined by the Board in its sole discretion,
                              then you shall immediately forfeit all rights to
                              your Option and the Option shall immediately
                              expire. For purposes of this Agreement, "Cause"
                              shall mean the termination of your Service due to
                              your commission of any act of fraud, embezzlement
                              or dishonesty; any unauthorized use or disclosure
                              of confidential information or trade secrets of
                              the Company (or any Parent, Subsidiary or
                              Affiliate); or any other intentional misconduct
                              adversely affecting the business or affairs of the
                              Company (or any Parent, Subsidiary or Affiliate)
                              in a material manner. This definition shall not
                              restrict in any way the Company's or any Parent's,
                              Subsidiary's or Affiliate's

                                       2

<PAGE>

                              right to discharge you for any other reason, nor
                              shall this definition be deemed to be inclusive of
                              all the acts or omissions which constitute "cause"
                              for purposes other than this Agreement.

Death                         If your Service terminates because of your death,
                              then your Option will expire at the close of
                              business at Company headquarters on the date
                              twelve (12) months after the date of death. During
                              that twelve (12) month period, your estate or
                              heirs may exercise the vested portion of your
                              Option.

Disability                    If your Service terminates because of your
                              Disability, then your Option will expire at the
                              close of business at Company headquarters on the
                              date twelve (12) months after your termination
                              date.

Leaves of Absence             For purposes of this Option, your Service does not
                              terminate when you go on a bona fide leave of
                              absence that was approved by the Company in
                              writing, if the terms of the leave provide for
                              continued Service crediting, or when continued
                              Service crediting is required by applicable law.
                              Your Service terminates in any event when the
                              approved leave ends unless you immediately return
                              to active work.

                              The Company determines which leaves count for this
                              purpose, and when your Service terminates for all
                              purposes under the Plan.

Notice of Exercise            When you wish to exercise this Option, you must
                              notify the Company by filing the proper "Notice of
                              Exercise" form at the address given on the form.
                              Your notice must specify how many Shares you wish
                              to purchase. Your notice must also specify how
                              your Shares should be registered (in your name
                              only or in your and your spouse's names as
                              community property or as joint tenants with right
                              of survivorship). The notice will be effective
                              when it is received by the Company.

                              If someone else wants to exercise this Option
                              after your death, that person must prove to the
                              Company's satisfaction that he or she is entitled
                              to do so.

Form of Payment               When you submit your notice of exercise, you must
                              include payment of the Exercise Price for the
                              Shares you are purchasing. Payment may be made in
                              one (or a combination) of the following forms:

                              .  Cash, your personal check, a cashier's check, a
                                 money

                                       3

<PAGE>

                                      order or an electronic funds transfer.

                                   .  Shares which have already been owned by
                                      you for more than six months and which are
                                      surrendered to the Company. The value of
                                      the Shares, determined as of the effective
                                      date of the Option exercise, will be
                                      applied to the Exercise Price.

                                   .  To the extent a public market for the
                                      Shares exists as determined by the
                                      Company, by delivery (on a form prescribed
                                      by the Company) of an irrevocable
                                      direction to a securities broker to sell
                                      Shares and to deliver all or part of the
                                      sale proceeds to the Company in payment of
                                      the aggregate exercise price.

Withholding Taxes                  You will not be allowed to exercise this
                                   Option unless you make acceptable
                                   arrangements to pay any withholding or other
                                   taxes that may be due as a result of the
                                   Option exercise or sale of Shares acquired
                                   under this Option.

Restrictions on Exercise and       By signing this Agreement, you agree not to
Resale                             exercise this Option or sell any Shares
                                   acquired under this Option at a time when
                                   applicable laws, regulations or Company or
                                   underwriter trading policies prohibit
                                   exercise, sale or issuance of Shares. The
                                   Company will not permit you to exercise this
                                   Option if the issuance of Shares at that time
                                   would violate any law or regulation. The
                                   Company shall have the right to designate one
                                   or more periods of time, each of which shall
                                   not exceed one hundred eighty (180) days in
                                   length, during which this Option shall not be
                                   exercisable if the Company determines (in its
                                   sole discretion) that such limitation on
                                   exercise could in any way facilitate a
                                   lessening of any restriction on transfer
                                   pursuant to the Securities Act or any state
                                   securities laws with respect to any issuance
                                   of securities by the Company, facilitate the
                                   registration or qualification of any
                                   securities by the Company under the
                                   Securities Act or any state securities laws,
                                   or facilitate the perfection of any exemption
                                   from the registration or qualification
                                   requirements of the Securities Act or any
                                   applicable state securities laws for the
                                   issuance or transfer of any securities. Such
                                   limitation on exercise shall not alter the
                                   vesting schedule set forth in this Agreement
                                   other than to limit the periods during which
                                   this Option shall be exercisable.

                                   If the sale of Shares under the Plan is not
                                   registered under the Securities Act, but an
                                   exemption is available which requires an
                                   investment or other representation, you shall
                                   represent and agree at the time of exercise
                                   that the Shares being acquired upon exercise
                                   of this Option are being acquired for
                                   investment,

                                       4

<PAGE>

                                   and not with a view to the sale or
                                   distribution thereof, and shall make such
                                   other representations as are deemed necessary
                                   or appropriate by the Company and its
                                   counsel.

Transfer of Option                 Prior to your death, only you may exercise
                                   this Option.  You cannot transfer or assign
                                   this Option. For instance, you may not sell
                                   this Option or use it as security for a loan.
                                   If you attempt to do any of these things,
                                   this Option will immediately become invalid.
                                   You may, however, dispose of this Option in
                                   your will. Regardless of any marital property
                                   settlement agreement, the Company is not
                                   obligated to honor a notice of exercise from
                                   your spouse, nor is the Company obligated to
                                   recognize your spouse's interest in your
                                   Option in any other way.

Retention Rights                   Your Option or this Agreement does not give
                                   you the right to be retained by the Company
                                   (or any Parent or any Subsidiaries or
                                   Affiliates) in any capacity. The Company (or
                                   any Parent and any Subsidiaries or
                                   Affiliates) reserves the right to terminate
                                   your Service at any time and for any reason.

Stockholder Rights                 You, or your estate or heirs, have no rights
                                   as a stockholder of the Company until a
                                   certificate for your Option's Shares has been
                                   issued. No adjustments are made for dividends
                                   or other rights if the applicable record date
                                   occurs before your stock certificate is
                                   issued, except as described in the Plan.

Adjustments                        In the event of a stock split, a stock
                                   dividend or a similar change in the Company
                                   stock, the number of Shares covered by this
                                   Option and the exercise price per Share may
                                   be adjusted (and rounded down to the nearest
                                   whole number) pursuant to the Plan. Your
                                   Option shall be subject to the terms of the
                                   agreement of merger, liquidation or
                                   reorganization in the event the Company is
                                   subject to such corporate activity.

Legends                            All certificates representing the Shares
                                   issued upon exercise of this Option shall,
                                   where applicable, have endorsed thereon the
                                   following legends (or such other legend(s) as
                                   may be necessary to comply with applicable
                                   state or federal securities laws):

                                       "THE SHARES REPRESENTED BY THIS
                                       CERTIFICATE ARE SUBJECT TO CERTAIN
                                       RESTRICTIONS ON TRANSFER AND OPTIONS TO
                                       PURCHASE SUCH SHARES SET FORTH IN AN
                                       AGREEMENT BETWEEN THE COMPANY AND THE
                                       REGISTERED HOLDER, OR HIS OR HER
                                       PREDECESSOR IN INTEREST. A COPY OF SUCH
                                       AGREEMENT IS ON FILE AT THE PRINCIPAL

                                       5

<PAGE>

                                       OFFICE OF THE COMPANY AND WILL BE
                                       FURNISHED UPON WRITTEN REQUEST TO THE
                                       SECRETARY OF THE COMPANY BY THE HOLDER OF
                                       RECORD OF THE SHARES REPRESENTED BY THIS
                                       CERTIFICATE."

                                       "THE SHARES REPRESENTED HEREBY HAVE NOT
                                       BEEN REGISTERED UNDER THE SECURITIES ACT
                                       OF 1933, AS AMENDED, AND MAY NOT BE SOLD,
                                       PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT
                                       AN EFFECTIVE REGISTRATION THEREOF UNDER
                                       SUCH ACT OR AN OPINION OF COUNSEL,
                                       SATISFACTORY TO THE COMPANY AND ITS
                                       COUNSEL, THAT SUCH REGISTRATION IS NOT
                                       REQUIRED."

Applicable Law                     This Agreement will be interpreted and
                                   enforced under the laws of the State of
                                   California.

          By signing the cover sheet of this Agreement, you agree to all of the
          terms and conditions described above and in the Plan.

                                       6<PAGE>

                                                                   Exhibit 10.11

                           IMPAC MEDICAL SYSTEMS, INC.

                          INVESTORS' RIGHTS AGREEMENT

                                 October 9, 1996

<PAGE>

                               TABLE OF CONTENTS
                               -----------------

<TABLE>
<CAPTION>
Description                                                                           Page
-----------                                                                           ----
<S>                                                                                    <C>
1    Registration Rights .......................................................       1
        1 1  Definitions .......................................................       1
        1.2  Request for Registration ..........................................       2
        1.3  Company Registration.. ............................................       3
        1.4  Obligations of the Company ........................................       4
        1.5  Furnish Information ...............................................       5
        1.6  Expenses of Demand Registration. ..................................       6
        1.7  Expenses of Company Registration ..................................       6
        1.8  Underwriting Requirements .........................................       6
        1.9  Delay of Registration .............................................       7
        1.10 Indemnification ...................................................       7
        1.11 Reports Under Securities Exchange Act of 1934 .....................       9
        1.12 Form S-3 Registration .............................................      10
        1.13 Assignment of Registration Rights .................................      11
        1.14 Limitations on Subsequent Registration Rights .....................      11
        1.15 "Market Stand-Off" Agreement ......................................      11
        1.16 Termination of Registration Rights ................................      12
2. Covenants of the Company ....................................................      12
        2.1  Delivery of Financial Statements ..................................      12
        2.2  Inspection ........................................................      13
        2.3  Encumbrance of Assets .............................................      13
        2.4  Termination of Information and Inspection Covenants ...............      14
        2.5  Right of First Offer ..............................................      14
3. Repurchase ..................................................................      15
        3.1  Repurchase Request ................................................      15
        3.2  Notice ............................................................      16
        3.3  Availability of Funds .............................................      16
        3.4  Fair Market Value .................................................      17
        3.5  Conflicts with Articles ...........................................      17
4. Covenants of the Investors ..................................................      17
        4.1  Company Right of First Offer ......................................      17
        4.2  Covenant by Summit Partners .......................................      18
5  Miscellaneous ...............................................................      18
        5.1  Successors and Assigns ............................................      18
        5.2  Governing Law .....................................................      18
        5.3  Counterparts ......................................................      18
        5.4  Titles and Subtitles ..............................................      18
        5.5  Notices ...........................................................      19
        5.6  Amendments and Waivers ............................................      19
        5.7  Severability ......................................................      19
        5.8  Aggregation of Stock ..............................................      19
</TABLE>

<PAGE>

                           IMPAC MEDICAL SYSTEMS, INC.

                           INVESTORS' RIGHTS AGREEMENT
                           ---------------------------

         This Investors' Rights Agreement (the "Agreement") is made as of the
                                                ---------
 9th day of October, 1996, by and among IMPAC Medical Systems, Inc., a
 California corporation (the "Company"), and each of the investors listed on
                              -------
 Exhibit A hereto.
 ---------

                                    RECITALS
                                    --------

         The Company and the Investors have entered into a Series A Preferred
Stock Purchase Agreement (the "Purchase Agreement") of even date herewith
                               ------------------
pursuant to which the Company desires to sell to the Investors and the Investors
desire to purchase from the Company shares of the Company's Series A Preferred
Stock. A condition to the Investors' obligations under the Purchase Agreement is
that the Company and the Investors enter into this Agreement in order to provide
the Investors with (i) certain rights to register shares of the Company's Common
Stock issuable upon conversion of the Series A Preferred Stock held by the
Investors, (ii) certain rights to receive or inspect information pertaining to
the Company, and (iii) a right of first offer with respect to certain issuances
by the Company of its securities. The Company and the Investors each desire to
induce the Investors to purchase shares of Series A Preferred Stock pursuant to
the Purchase Agreement by agreeing to the terms and conditions set forth herein.

                                    AGREEMENT
                                    ---------

                  1.      Registration Rights. The Company and the Investors
                          -------------------
covenant and agree as follows:

                          1.1  Definitions. For purposes of this Section 1:
                               -----------

                               (a)   The terms "register," "registered," and
                                                --------    ----------
"registration" refer to a registration effected by preparing and filing a
 ------------
registration statement or similar document in compliance with the Securities Act
of 1933, as amended (the "Act"), and the declaration or ordering of
                          ---
effectiveness of such registration statement or document;

                               (b)   The term "Registrable Securities" means (i)
                                               ----------------------
the shares of Common Stock issuable or issued upon conversion of the Series A
Preferred Stock (such shares of Common Stock are collectively referred to
hereinafter as the "Stock"), and (ii) any other shares of Common Stock of the
                    -----
Company issued as (or issuable upon the conversion or exercise of any warrant,
right or other security which is issued as) a dividend or other distribution
with respect to, or in exchange for or in replacement of, the Stock, provided
                                                                     --------
that the foregoing definition shall exclude in all cases any Registrable
Securities sold by a person in a transaction in which his or her rights under
this Agreement are not assigned. Notwithstanding the foregoing, Common Stock or
other securities shall only be treated as Registrable Securities if and so long
as they have not been (A) sold to or through a broker or dealer or underwriter
in a public distribution or a public securities transaction, or (B) sold in a
transaction exempt from the registration and prospectus

<PAGE>

delivery requirements of the Act under Section 4(1) thereof so that all transfer
restrictions, and restrictive legends with respect thereto, if any, are removed
upon the consummation of such sale;

                               (c)   The number of shares of "Registrable
                                                              -----------
Securities then outstanding" shall be determined by the number of shares of
---------------------------
Common Stock outstanding which are, and the number of shares of Common Stock
issuable pursuant to then exercisable or convertible securities which are,
Registrable Securities;

                               (d)   The term "Holder" means any person owning
                                               ------
or having the right to acquire Registrable Securities or any assignee thereof in
accordance with Section 1.13 hereof;

                               (e)   The term "Form S-3" means such form under
                                               --------
the Act as in effect on the date hereof or any successor form under the Act; and

                               (f)   The term "SEC" means the Securities and
                                               ---
Exchange Commission.

                          1.2  Request for Registration.
                               -------------------------

                               (a)   If the Company shall receive at any time
after six (6) months after the effective date of the first registration
statement for a public offering of securities of the Company (other than a
registration statement relating either to the sale of securities to employees of
the Company pursuant to a stock option, stock purchase or similar plan or an SEC
Rule 145 transaction), a written request from the Holders of a majority of the
Registrable Securities then outstanding that the Company file a registration
statement under the Act covering the registration of at least twenty percent
(20%) of the Registrable Securities then outstanding (or a lesser percent if the
anticipated aggregate offering price, net of underwriting discounts and
commissions, would exceed $5,000,000), then the Company shall, within ten (10)
days of the receipt thereof, give written notice of such request to all Holders
and shall, subject to the limitations of subsection 1.2(b), use its best efforts
to effect, as soon as practicable and in any event within 60 days of the receipt
of such request, the registration under the Act of all Registrable Securities
which the Holders request to be registered within twenty (20) days of the
mailing of such notice by the Company in accordance with Section 3.5.

                               (b)   If the Holders initiating the registration
request hereunder ("Initiating Holders") intend to distribute the Registrable
                    ------------------
Securities covered by their request by means of an underwriting, they shall so
advise the Company as a part of their request made pursuant to this Section 1.2
and the Company shall include such information in the written notice referred to
in subsection l.2(a). The underwriter will be selected by a majority in interest
of the Initiating Holders and shall be reasonably acceptable to the Company. In
such event, the right of any Holder to include his Registrable Securities in
such registration shall be conditioned upon such Holder's participation in such
underwriting and the inclusion of such Holder's Registrable Securities in the
underwriting (unless otherwise mutually agreed by a majority in interest of the
Initiating Holders and such Holder) to the extent provided herein. All Holders
proposing to distribute their securities through such underwriting shall
(together with the Company as provided

                                       -2-

<PAGE>

in subsection 1.4(e)) enter into an underwriting agreement in customary form
with the underwriter or underwriters selected for such underwriting by a
majority in interest of the Initiating Holders. Notwithstanding any other
provision of this Section 1.2, if the underwriter advises the Initiating Holders
in writing that marketing factors require a limitation of the number of shares
to be underwritten, then the Initiating Holders shall so advise all Holders of
Registrable Securities which would otherwise be underwritten pursuant hereto,
and the number of shares of Registrable Securities that may be included in the
underwriting shall be allocated among all Holders thereof, including the
Initiating Holders, in proportion (as nearly as practicable) to the amount-of
Registrable Securities of the Company owned by each Holder; provided, however,
                                                            --------  -------
that the number of shares of Registrable Securities to be included in such
underwriting shall not be reduced unless all other securities are first entirely
excluded from the underwriting.

                  (c)  Notwithstanding the foregoing, if the Company shall
furnish to Holders requesting a registration statement pursuant to this Section
1.2, a certificate signed by the President of the Company stating that in the
good faith judgment of the Board of Directors of the Company, it would be
seriously detrimental to the Company and its shareholders for such registration
statement to be filed and it is therefore essential to defer the filing of such
registration statement, the Company shall have the right to defer such filing
for a period of not more than 90 days after receipt of the request of the
Initiating Holders; provided, however, that the Company may not utilize this
                    --------  -------
right more than once in any twelve-month period.

                  (d)  In addition, the Company shall not be obligated to
effect, or to take any action to effect, any registration pursuant to this
Section 1.2:

                       (i)   After the Company has effected two (2)
registrations pursuant to this Section 1.2 and such registrations have been
declared or ordered effective;

                       (ii)  During the period starting with the date sixty (60)
days prior to the Company's good faith estimate of the date of filing of, and
ending on a date one hundred eighty (180) days after the effective date of, a
registration subject to Section 1.3 hereof; provided that the Company is
actively employing in good faith all reasonable efforts to cause such
registration statement to become effective; or

                       (iii) If the Initiating Holders propose to dispose of
shares of Registrable Securities that may be immediately registered on Form S-3
pursuant to a request made pursuant to Section 1.12 below.

             1.3  Company Registration. If (but without any obligation to do so)
                  --------------------
the Company proposes to register (including for this purpose a registration
effected by the Company for shareholders other than the Holders) any of its
stock under the Act in connection with the public offering of such securities
solely for cash (other than a registration relating solely to the sale of
securities to participants in a Company employee benefit plan or a transaction
covered by Rule 145 under the Act, a registration in which the only stock being
registered is Common Stock issuable upon conversion of debt securities which are
also being registered, or any registration on any form which does not include
substantially the same information as would be required to be included in a
registration statement covering the sale of the Registrable Securities),

                                      -3-

<PAGE>

the Company shall, at such time, promptly give each Holder written notice of
such registration. Upon the written request of each Holder given within twenty
(20) days after mailing of such notice by the Company in accordance with Section
5.5, the Company shall, subject to the provisions of Section 1.8, cause to be
registered under the Act all of the Registrable Securities that each such Holder
has requested to be registered.

           1.4 Obligations of the Company. Whenever required under this Section
               --------------------------
1 to effect the registration of any Registrable Securities, the Company shall,
as expeditiously as reasonably possible:

               (a) Prepare and file with the SEC a registration statement with
respect to such Registrable Securities and use its best efforts to cause such
registration statement to become effective, and, upon the request of the Holders
of a majority of the Registrable Securities registered thereunder, keep such
registration statement effective for a period of up to the shorter of ninety
(90) days or until the distribution contemplated in the registration statement
has been completed, provided, however, that such ninety (90) day period shall be
extended for a period of time equal to the period the Holder refrains from
selling any securities included in such registration at the request of the
Company or an underwriter of Common Stock (or other securities) of the Company.

               (b) Prepare and file with the SEC such amendments and supplements
to such registration statement and the prospectus used in connection with such
registration statement as may be necessary to comply with the provisions of the
Act with respect to the disposition of all securities covered by such
registration statement for a period of up to the shorter of ninety (90) days or
until the distribution contemplated in the registration statement has been
completed, provided, however, that such ninety (90) day period shall be extended
for a period of time equal to the period the Holder refrains from selling any
securities included in such registration at the request of the Company or an
underwriter of Common Stock (or other securities) of the Company.

               (c) Furnish to the Holders such numbers of copies of a
prospectus, including a preliminary prospectus, in conformity with the
requirements of the Act, and such other documents as they may reasonably request
in order to facilitate the disposition of Registrable Securities owned by them.

               (d) Use its best efforts to register and qualify the securities
covered by such registration statement under such other securities or Blue Sky
laws of such jurisdictions as shall be reasonably requested by the Holders,
provided that the Company shall not be required in connection therewith or as a
condition thereto to qualify to do business or to file a general consent to
service of process in any such states or jurisdictions.

               (e) In the event of any underwritten public offering, enter into
and perform its obligations under an underwriting agreement, in usual and
customary form, with the managing underwriter of such offering. Each Holder
participating in such underwriting shall also enter into and perform its
obligations under such an agreement.

                                       -4-

<PAGE>

              (f) Notify each Holder of Registrable Securities covered by such
registration statement at any time when a prospectus relating thereto is
required to be delivered under the Act of the happening of any event as a result
of which the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading in the light of the circumstances then existing, such
obligation to continue for a period of up to the shorter of ninety (90) days or
until the distribution contemplated in the registration statement has been
completed, provided, however, that such ninety (90) day period shall be extended
for a period of time equal to the period the Holder refrains from selling any
securities included in such registration at the request of the Company or an
underwriter of Common Stock (or other securities) of the Company.

              (g) Cause all such Registrable Securities registered pursuant
hereunder to be listed on each securities exchange on which similar securities
issued by the Company are then listed.

              (h) Provide a transfer agent and registrar for all Registrable
Securities registered pursuant hereunder and a CUSIP number for all such
Registrable Securities, in each case not later than the effective date of such
registration.

              (i) Use its best efforts to furnish, at the request of any Holder
requesting registration of Registrable Securities pursuant to this Section 1, on
the date that such Registrable Securities are delivered to the underwriters for
sale in connection with a registration pursuant to this Section 1, if such
securities are being sold through underwriters, or, if such securities are not
being sold through underwriters, on the date that the registration statement
with respect to such securities becomes effective, (i) an opinion, dated such
date, of the counsel representing the Company for the purposes of such
registration, in form and substance as is customarily given to underwriters in
an underwritten public offering, addressed to the underwriters, if any, and to
the Holders requesting registration of Registrable Securities and (ii) a letter
dated such date, from the independent certified public accountants of the
Company, in form and substance as is customarily given by independent certified
public accountants to underwriters in an underwritten public offering, addressed
to the underwriters, if any, and to the Holders requesting registration of
Registrable Securities.

          1.5 Furnish Information. It shall be a condition precedent to the
              -------------------
obligations of the Company to take any action pursuant to this Section 1 with
respect to the Registrable Securities of any selling Holder that such Holder
shall furnish to the Company such information regarding itself, the Registrable
Securities held by it, and the intended method of disposition of such securities
as shall be required to effect the registration of such Holder's Registrable
Securities. The Company shall have no obligation with respect to any
registration requested pursuant to Section 1.2 or Section 1.12 of this Agreement
if, as a result of the application of the preceding sentence, the number of
shares or the anticipated aggregate offering price of the Registrable Securities
to be included in the registration does not equal or exceed the number of shares
or the anticipated aggregate offering price required to originally trigger the
Company's obligation to initiate such registration as specified in subsection
1.2(a) or subsection 1.12(b)(2), whichever is applicable.

                                       -5-

<PAGE>

              1.6 Expenses of Demand Registration. All expenses other than
                  -----------------------------
underwriting discounts and commissions incurred in connection with
registrations, filings or qualifications pursuant to Section 1.2, including
(without limitation) all registration, filing and qualification fees, printers'
and accounting fees, fees and disbursements of counsel for the Company, and the
reasonable fees and disbursements of one counsel for the selling Holders shall
be borne by the Company; provided, however, that the Company shall not be
required to pay for any expenses of any registration proceeding begun pursuant
to Section 1.2 if the registration request is subsequently withdrawn at the
request of the Holders of a majority of the Registrable Securities to be
registered (in which case all participating Holders shall bear such expenses),
unless the Holders of a majority of the Registrable Securities agree to forfeit
their right to one demand registration pursuant to Section 1.2; provided
further, however, that if at the time of such withdrawal, the Holders have
learned of a material adverse change in the condition, business, or prospects of
the Company from that known to the Holders at the time of their request and have
withdrawn the request with reasonable promptness following disclosure by the
Company of such material adverse change, then the Holders shall not be required
to pay any of such expenses and shall retain their rights pursuant to Section
1.2.

              1.7 Expenses of Company Registration. The Company shall bear and
                  ---------------------------------
pay all expenses incurred in connection with any registration, filing or
qualification of Registrable Securities with respect to the registrations
pursuant to Section 1.3 for each Holder (which right may be assigned as provided
in Section 1.13), including (without limitation) all registration, fling, and
qualification fees, printers' and accounting fees relating or apportionable
thereto and the reasonable fees and disbursements of one counsel for the selling
Holders selected by them with the approval of the Company, which approval shall
not be unreasonably withheld, but excluding underwriting discounts and
commissions relating to Registrable Securities.

              1.8 Underwriting Requirements. In connection with any offering
                  -------------------------
involving an underwriting of shares of the Company's capital stock, the Company
shall not be required under Section 1.3 to include any of the Holders'
securities in such underwriting unless they accept the terms of the underwriting
as agreed upon between the Company and the underwriters selected by it (or by
other persons entitled to select the underwriters), and then only in such
quantity as the underwriters determine in their sole discretion will not
jeopardize the success of the offering by the Company. If the total amount of
securities, including Registrable Securities, requested by shareholders to be
included in such offering exceeds the amount of securities sold other than by
the Company that the underwriters determine in their sole discretion is
compatible with the success of the offering, then the Company shall be required
to include in the offering only that number of such securities, including
Registrable Securities, which the underwriters determine in their sole
discretion will not jeopardize the success of the offering (the securities so
included to be apportioned pro rata among the selling shareholders according to
the total amount of securities entitled to be included therein owned by each
selling shareholder or in such other proportions as shall mutually be agreed to
by such selling shareholders) but in no event shall (i) the amount of securities
of the selling Holders included in the offering be reduced below thirty percent
(30%) of the total amount of securities included in such offering, unless such
offering is the initial public offering of the Company's securities in which
case the selling shareholders may be excluded if the underwriters make the
determination described above and no other shareholder's securities are included
or (ii) notwithstanding (i) above, any shares being sold by a

                                       -6-

<PAGE>

shareholder exercising a demand registration right similar to that granted in
Section 1.2 be excluded from such offering. For purposes of the preceding
parenthetical concerning apportionment, for any selling shareholder which is a
Holder of Registrable Securities and which is a partnership or corporation, the
partners, retired partners and shareholders of such Holder, or the estates and
family members of any such partners and retired partners and any trusts for the
benefit of any of the foregoing persons shall be deemed to be a single "selling
                                                                        -------
shareholder," and any pro-rata reduction with respect to such "selling
-----------
shareholder" shall be based upon the aggregate amount of shares carrying
registration rights owned by all entities and individuals included in such
"selling shareholder," as defined in this sentence.

                1.9   Delay of Registration. No Holder shall have any right to
                      ---------------------
obtain or seek an injunction restraining or otherwise delaying any such
registration as the result of any controversy that might arise with respect to
the interpretation or implementation of this Section 1.

                1.10  Indemnification. In the event any Registrable Securities
                      ---------------
are included in a registration statement under this Section 1:

                      (a)  To the extent permitted by law, the Company will
indemnify and hold harmless each Holder, any underwriter (as defined in the Act)
for such Holder and each person, if any, who controls such Holder or underwriter
within the meaning of the Act or the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), against any losses, claims, damages, or liabilities (joint
      ------------
or several) to which they may become subject under the Act, the Exchange Act or
other federal or state law, insofar as such losses, claims, damages, or
liabilities (or actions in respect thereof) arise out of or are based upon any
of the following statements, omissions or violations (collectively a
"Violation"): (i) any untrue statement or alleged untrue statement of a material
 ---------
fact contained in such registration statement, including any preliminary
prospectus or final prospectus contained therein or any amendments or
supplements thereto, (ii) the omission or alleged omission to state therein a
material fact required to be stated therein, or necessary to make the statements
therein not misleading, or (iii) any violation or alleged violation by the
Company of the Act, the Exchange Act, any state securities law or any rule or
regulation promulgated under the Act, the Exchange Act or any state securities
law; and the Company will pay to each such Holder, underwriter or controlling
person, as incurred, any legal or other expenses reasonably incurred by them in
connection with investigating or defending any such loss, claim, damage,
liability, or action; provided, however, that the indemnity agreement contained
in this subsection 1.10(a) shall not apply to amounts paid in settlement of any
such loss, claim, damage, liability, or action if such settlement is effected
without the consent of the Company (which consent shall not be unreasonably
withheld), nor shall the Company be liable in any such case for any such loss,
claim, damage, liability, or action to the extent that it arises out of or is
based upon a Violation which occurs in reliance upon and in conformity with
written information furnished expressly for use in connection with such
registration by any such Holder, underwriter or controlling person.

                      (b)  To the extent permitted by law, each selling Holder
will indemnify and hold harmless the Company, each of its directors, each of its
officers who has signed the registration statement; each person, if any, who
controls the Company within the meaning of the Act, any underwriter, any other
Holder selling securities in such registration

                                      -7-

<PAGE>

statement and any controlling person of any such underwriter or other Holder,
against any losses, claims, damages, or liabilities (joint or several) to which
any of the foregoing persons may become subject, under the Act, the Exchange
Act or other federal or state law, insofar as such losses, claims, damages, or
liabilities (or actions in respect thereto) arise out of or are based upon any
Violation, in each case to the extent (and only to the extent) that such
Violation occurs in reliance upon and in conformity with written information
furnished by such Holder expressly for use in connection with such registration;
and each such Holder will pay, as incurred, any legal or other expenses
reasonably incurred by any person intended to be indemnified pursuant to this
subsection 1.10(b), in connection with investigating or defending any such loss,
claim, damage, liability, or action; provided, however, that the indemnity
agreement contained in this subsection 1.10(b) shall not apply to amounts paid
in settlement of any such loss, claim, damage, liability or action if such
settlement is effected without the consent of the Holder, which consent shall
not be unreasonably withheld; provided, that, in no event shall any indemnity
under this subsection 1.10(b) exceed the net proceeds from the offering received
by such Holder, except in the case of willful fraud by such Holder.

                (c)  Promptly after receipt by an indemnified party under this
Section 1.10 of notice of the commencement of any action (including any
governmental action), such indemnified party will, if a claim in respect thereof
is to be made against any indemnifying party under this Section 1.10, deliver to
the indemnifying party a written notice of the commencement thereof and the
indemnifying party shall have the right to participate in, and, to the extent
the indemnifying party so desires, jointly with any other indemnifying party
similarly noticed, to assume the defense thereof with counsel mutually
satisfactory to the parties; provided, however, that an indemnified party
(together with all other indemnified parties which may be represented without
conflict by one counsel) shall have the right to retain one separate counsel,
with the reasonable fees and expenses to be paid by the indemnifying party, if
representation of such indemnified party by the counsel retained by the
indemnifying party would be inappropriate due to actual or potential differing
interests between such indemnified party and any other party represented by such
counsel in such proceeding. The failure to deliver written notice to the
indemnifying party within a reasonable time of the commencement of any such
action, if prejudicial to its ability to defend such action, shall relieve
such indemnifying party of any liability to the indemnified party under this
Section 1.10, but the omission so to deliver written notice to the indemnifying
party will not relieve it of any liability that it may have to any indemnified
party otherwise than under this Section 1.10.

                (d)  If the indemnification provided for in this Section 1.10 is
held by a court of competent jurisdiction to be unavailable to an indemnified
party with respect to any loss, liability, claim, damage, or expense referred to
therein, then the indemnifying party, in lieu of indemnifying such indemnified
party hereunder, shall contribute to the amount paid or payable by such
indemnified party as a result of such loss, liability, claim, damage, or expense
in such proportion as is appropriate to reflect the relative fault of the
indemnifying party on the one hand and of the indemnified party on the other in
connection with the statements or omissions that resulted in such loss,
liability, claim, damage, or expense as well as any other relevant equitable
considerations; provided, that, in no event shall any contribution by a Holder
under this Subsection 1.10(d) exceed the net proceeds from the offering received
by such Holder, except in the case of willful fraud by such Holder. The relative
fault of the indemnifying party and of the

                                      -8-

<PAGE>

indemnified party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the
omission to state a material fact relates to information supplied by the
indemnifying party or by the indemnified party and the parties' relative intent,
knowledge, access to information, and opportunity to correct or prevent such
statement or omission.

               (e) Notwithstanding the foregoing, to the extent that the
provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are
in conflict with the foregoing provisions, the provisions in the underwriting
agreement shall control.

               (f) The obligations of the Company and Holders under this Section
1.10 shall survive the completion of any offering of Registrable Securities in a
registration statement under this Section 1, and otherwise.

          1.11 Reports Under Securities Exchange Act of 1934. With a view to
               ---------------------------------------------
making available to the Holders the benefits of Rule 144 promulgated under the
Act and any other rule or regulation of the SEC that may at any time permit a
Holder to sell securities of the Company to the public without registration or
pursuant to a registration on Form S-3, the Company agrees to:

               (a) make and keep public information available, as those terms
are understood and defined in SEC Rule 144, at all times after ninety (90) days
after the effective date of the first registration statement filed by the
Company for the offering of its securities to the general public so long as the
Company remains subject to the periodic reporting requirements under Sections 13
or 15(d) of the Exchange Act;

               (b) take such action, including the voluntary registration of its
Common Stock under Section 12 of the Exchange Act, as is necessary to enable the
Holders to utilize Form S-3 for the sale of their Registrable Securities, such
action to be taken as soon as practicable after the end of the fiscal year in
which the first registration statement filed by the Company for the offering of
its securities to the general public is declared effective;

               (c) file with the SEC in a timely manner all reports and other
documents required of the Company under the Act and the Exchange Act; and

               (d) furnish to any Holder, so long as the Holder owns any
Registrable Securities, forthwith upon request (i) a written statement by the
Company that it has complied with the reporting requirements of SEC Rule 144 (at
any time after ninety (90) days after the effective date of the first
registration statement filed by the Company), the Act and the Exchange Act (at
any time after it has become subject to such reporting requirements), or that it
qualifies as a registrant whose securities may be resold pursuant to Form S-3
(at any time after it so qualifies), (ii) a copy of the most recent annual or
quarterly report of the Company and such other reports and documents so filed by
the Company, and (iii) such other information as may be reasonably requested in
availing any Holder of any rule or regulation of the SEC which permits the
selling of any such securities without registration or pursuant to such form.

                                       -9-

<PAGE>

                  1.12     Form S-3 Registration. In case the Company shall
                           ---------------------
receive from any Holder or Holders of not less than twenty percent (20%) of the
Registrable Securities then outstanding a written request or requests that the
Company effect a registration on Form S-3 and any related qualification or
compliance with respect to all or a part of the Registrable Securities owned by
such Holder or Holders, the Company will:

                           (a)    promptly give written notice of the proposed
registration, and any related qualification or compliance, to all other Holders;
and

                           (b)    as soon as practicable, effect such
registration and all such qualifications and compliances as may be so requested
and as would permit or facilitate the sale and distribution of all or such
portion of such Holder's Registrable Securities as are specified in such
request, together with all or such portion of the Registrable Securities of any
other Holder or Holders joining in such request as are specified in a written
request given within 15 days after receipt of such written notice from the
Company; provided, however, that the Company shall not be obligated to effect
         --------  -------
any such registration, qualification or compliance, pursuant to this Section
1.12: (1) if Form S-3 is not available for such offering by the Holders; (2) if
the Holders, together with the holders of any other securities of the Company
entitled to inclusion in such registration, propose to sell Registrable
Securities and such other securities (if any) at an aggregate price to the
public (net of any underwriters' discounts or commissions) of less than
$500,000; (3) if the Company shall furnish to the Holders a certificate signed
by the President of the Company stating that in the good faith judgment of the
Board of Directors of the Company, it would be seriously detrimental to the
Company and its shareholders for such Form S-3 Registration to be effected at
such time, in which event the Company shall have the right to defer the filing
of the Form S-3 registration statement for a period of not more than 90 days
after receipt of the request of the Holder or Holders under this Section 1.12;
provided, however, that the Company shall not utilize this right more than once
in any twelve month period; (4) if the Company has, within the twelve (12) month
period preceding the date of such request, already effected two registrations on
Form S-3 for the Holders pursuant to this Section 1.12; or (5) in any particular
jurisdiction in which the Company would be required to qualify to do business or
to execute a general consent to service of process in effecting such
registration, qualification or compliance.

                           (c)    Subject to the foregoing, the Company shall
file a registration statement covering the Registrable Securities and other
securities so requested to be registered as soon as practicable after receipt of
the request or requests of the Holders. All expenses incurred in connection with
a registration requested pursuant to Section 1.12, including (without
limitation) all registration, filing, qualification, printers' and accounting
fees and the reasonable fees and disbursements of counsel for the selling Holder
or Holders and counsel for the Company, but excluding any underwriters'
discounts or commissions associated with Registrable Securities, shall be borne
pro rata by the Holder or Holders participating in the Form S-3 Registration.
Registrations effected pursuant to this Section 1.12 shall not be counted as
demands for registration or registrations effected pursuant to Sections 1.2 or
1.3, respectively.

                  1.13     Assignment of Registration Rights. The rights to
                           ---------------------------------
cause the Company to register Registrable Securities pursuant to this Section 1
may be assigned (but only

                                      -10-

<PAGE>

with all related obligations) by a Holder to a transferee or assignee of at
least 100,000 shares of such securities, provided the Company is, within a
reasonable time after such transfer, furnished with written notice of the name
and address of such transferee or assignee and the securities with respect to
which such registration rights are being assigned; and provided, further, that
such assignment shall be effective only if immediately following such transfer
the further disposition of such securities by the transferee or assignee is
restricted under the Act. For the purposes of determining the number of shares
of Registrable Securities held by a transferee or assignee, the holdings of
transferees and assignees of a partnership who are partners or retired partners
of such partnership (including spouses and ancestors, lineal descendants and
siblings of such partners or spouses who acquire Registrable Securities by gift,
will or intestate succession) shall be aggregated together and with the
partnership; provided that all assignees and transferees who would not qualify
individually for assignment of registration rights shall have a single
attorney-in-fact for the purpose of exercising any rights, receiving notices or
taking any action under Section 1.

                  1.14     Limitations on Subsequent Registration Rights. From
                           ---------------------------------------------
and after the date of this Agreement, the Company shall not, without the prior
written consent of the Holders of a majority of the outstanding Registrable
Securities, enter into any agreement with any holder or prospective holder of
any securities of the Company which would allow such holder or prospective
holder (a) to include such securities in any registration filed under Section
1.2 hereof, unless under the terms of such agreement, such holder or prospective
holder may include such securities in any such registration only to the extent
that the inclusion of his securities will not reduce the amount of the
Registrable Securities of the Holders which is included or (b) to make a demand
registration which could result in such registration statement being declared
effective prior to the earlier of either of the dates set forth in subsection
1.2(a) or within one hundred twenty (120) days of the effective date of any
registration effected pursuant to Section 1.2.

                  1.15     "Market Stand-Off" Agreement. Each Holder hereby
                            ---------------------------
agrees that, during the period of duration (up to, but not exceeding, 180 days)
specified by the Company and an underwriter of Common Stock or other securities
of the Company, following the date of the final prospectus distributed in
connection with a registration statement of the Company filed under the Act, it
shall not, to the extent requested by the Company and such underwriter, directly
or indirectly sell, offer to sell, contract to sell (including, without
limitation, any short sale), grant any option to purchase or otherwise transfer
or dispose of (other than to donees who agree to be similarly bound) any
securities of the Company held by it at any time during such period except
Common Stock included in such registration; provided, however, that:

                           (a)  such agreement shall be applicable only to the
first such registration statement of the Company which covers Common Stock (or
other securities) to be sold on its behalf to the public in an underwritten
offering; and

                           (b)  all officers and directors of the Company, all
three-percent or greater securityholders, and all other persons with
registration rights (whether or not pursuant to this Agreement) enter into
similar agreements.

                                      -11-

<PAGE>

               In order to enforce the foregoing covenant, the Company may
impose stop-transfer instructions with respect to the Registrable Securities of
each Holder (and the shares or securities of every other person subject to the
foregoing restriction) until the end of such period, and each Holder agrees
that, if so requested, such Holder will execute an agreement in the form
provided by the underwriter containing terms which are essentially consistent
with the provisions of this Section 1.15.

               Notwithstanding the foregoing, the obligations described in this
Section 1.15 shall not apply to a registration relating solely to employee
benefit plans on Form S-1 or Form S-8 or similar forms which may be promulgated
in the future, or a registration relating solely to an SEC Rule 145 transaction
on Form S-4 or similar forms which may be promulgated in the future.

               1.16 Termination of Registration Rights. No Holder shall be
                    ----------------------------------
entitled to exercise any right provided for in this Section 1 after the earlier
of (i) five (5) years following the consummation of the sale of securities
pursuant to a registration statement filed by the Company under the Act in
connection with the initial firm commitment underwritten offering of its
securities to the general public, or (ii) such time as Rule 144 or another
similar exemption under the Act is available for the sale of all of such
Holder's shares during a three (3)-month period without registration.

          2.   Covenants of the Company.
               ------------------------

               2.1  Delivery of Financial Statements. The Company shall deliver
                    --------------------------------
to each Investor holding, and to transferees of, at least 100,000 shares of
Registrable Securities:

                    (a)  as soon as practicable, but in any event within ninety
(90) days after the end of each fiscal year of the Company, an income statement
for such fiscal year, a balance sheet of the Company and statement of
shareholder's equity as of the end of such year, and a statement of cash flows
for such year, such year-end financial reports to be in reasonable detail,
prepared in accordance with generally accepted accounting principles ("GAAP"),
                                                                       ----
and audited and certified by an independent public accounting firm selected by
the Company within the group of "Big 6" accounting firms;

                    (b)  as soon as practicable, but in any event within thirty
(30) days after the end of each of the first three (3) quarters of each fiscal
year of the Company, an unaudited profit or loss statement, a statement of cash
flows for such fiscal quarter and an unaudited balance sheet as of the end of
such fiscal quarter;

                    (c) within thirty (30) days of the end of each month, an
unaudited income statement and a statement of cash flows and balance sheet for
and as of the end of such month, in reasonable detail;

                    (d)  as soon as practicable, but in any event thirty (30)
days prior to the end of each fiscal year, a budget and business plan for the
next fiscal year, prepared on a

                                      -12-

<PAGE>

monthly basis, including balance sheets and sources and applications of funds
statements for such months and, as soon as prepared, any other budgets or
revised budgets prepared by the Company,

                           (e)    with respect to the financial statements
called for in subsections (b) and (c) of this Section 2.1, an instrument
executed by the Chief Financial Officer or President of the Company and
certifying that such financials were prepared in accordance with GAAP
consistently applied with prior practice for earlier periods (with the exception
of footnotes that may be required by GAAP) and fairly present the financial
condition of the Company and its results of operation for the period specified,
subject to year-end audit adjustment, provided that the foregoing shall not
restrict the right of the Company to change its accounting principles consistent
with GAAP, if the Board of Directors determines that it is in the best interest
of the Company to do so; and

                           (f)    such other information relating to the
financial condition, business, prospects or corporate affairs of the Company as
the Investor or any assignee of the Investor may from time to time reasonably
request, provided, however, that the Company shall not be obligated under this
subsection (f) or any other subsection of Section 2.1 to provide information
which it deems in good faith to be a trade secret or similar confidential
information

                  2.2      Inspection. The Company shall permit each Investor
                           ----------
who holds not less than 100,000 shares of Registrable Securities, at such
Investor's expense, to visit and inspect the Company's properties, to examine
its books of account and records and to discuss the Company's affairs, finances
and accounts with its officers, all at such reasonable times as may be requested
by the Investor; provided, however, that the Company shall not be obligated
pursuant to this Section 2.2 to provide access to any information which it
reasonably considers to be a trade secret or similar confidential information.

                  2.3      Encumbrance of Assets. The Company shall not encumber
                           ---------------------
all or substantially all of its assets without the approval of the Company's
Board of Directors, which approval shall include the affirmative vote of the
director elected as the representative of the Series A Preferred Stock pursuant
to Article III, Section 3 of the Company's First Amended and Restated Articles
of Incorporation; provided, however, that this Section 2.3 shall not apply to
the encumbrance by the Company of all or substantially all of its assets in
connection with indebtedness incurred by the Company in the individual amount of
less than $25,000, provided, further, that the aggregate of such indebtedness
does not exceed $150,000.

                  2.4      Termination of Information and Inspection Covenants.
                           ---------------------------------------------------
The covenants set forth in Sections 2.1, 2.2 and 2.3 shall terminate as to
Investors and be of no further force or effect when the sale of securities
pursuant to a registration statement filed by the Company under the Act in
connection with the firm commitment underwritten offering of its securities to
the general public is consummated or when the Company first becomes subject to
the periodic reporting requirements of Sections 13 or 15(d) of the Exchange Act,
whichever event shall first occur.

                  2.5      Right of First Offer. Subject to the terms and
                           --------------------
conditions specified in this Section 2.4, the Company hereby grants to each
Major Investor (as hereinafter defined) a

                                          -13-

<PAGE>

right of first offer with respect to future sales by the Company of its Shares
(as hereinafter defined). For purposes of this Section 2.5, a "Major Investor"
                                                               --------------
shall mean any person who holds at least 10% of the Series A Preferred Stock (or
the Common Stock issued upon conversion thereof) issued pursuant to the Purchase
Agreement, whether through purchase of such shares pursuant to the purchase
Agreement or acquisition of such shares thereafter). For purposes of this
Section 2.5, Major Investor includes any general partners and affiliates of a
Major Investor. A Major Investor who chooses to exercise the right of first
offer may designate as purchasers under such right itself or its partners or
affiliates in such proportions as it deems appropriate.

               Each time the Company proposes to offer any shares of, or
securities convertible into or exercisable for any shares of, any class of its
capital stock ("Shares"), the Company shall first make an offering of such
                ------
Shares to each Major Investor in accordance with the following provisions:

                    (a) The Company shall deliver a notice by certified mail
("Notice") to the Major Investors stating (i) its bona fide intention to offer
  ------
such Shares, (ii) the number of such Shares to be offered, and (iii) the price
and terms, if any, upon which it proposes to offer such Shares.

                    (b) Within 15 calendar days after delivery of the Notice,
the Major Investor may elect to purchase or obtain, at the price and on the
terms specified in the Notice, up to that portion of such Shares which equals
the proportion that the number of shares of Common Stock issued and held, or
issuable upon conversion and exercise of all convertible or exercisable
securities then held, by such Major Investor bears to the total number of shares
of Common Stock then outstanding (assuming full conversion and exercise of all
convertible or exercisable securities). The Company shall promptly, in writing,
inform each Major Investor that purchases all the shares available to it (each,
a "Fully-Exercising Investor") of any other Major Investor's failure to do
   -------------------------
likewise. During the ten (10)-day period commencing after receipt of such
information, each Fully-Exercising Investor shall be entitled to obtain that
portion of the Shares for which Major Investors were entitled to subscribe but
which were not subscribed for by the Major Investors that is equal to the
proportion that the number of shares of Common Stock issued and held, or
issuable upon conversion and exercise of all convertible or exercisable
securities then held, by such Fully-Exercising Investor bears to the total
number of shares of Common Stock then outstanding (assuming full conversion and
exercise of all convertible or exercisable securities).

                    (c) The Company may, during the 45-day period following the
expiration of the period provided in subsection 2.4(b) hereof, offer the
remaining unsubscribed portion of the Shares to any person or persons at a price
not less than, and upon terms no more favorable to the offeree than those
specified in the Notice. If the Company does not enter into an agreement for the
sale of the Shares within such period, or if such agreement is not consummated
within 60 days of the execution thereof, the right provided hereunder shall be
deemed to be revived and such Shares shall not be offered unless first reoffered
to the Major Investors in accordance herewith.

                                      -14-

<PAGE>

         (d)   The right of first offer in this paragraph 2.4 shall not be
applicable (i) to the issuance or sale of up to 414,000 shares of Common Stock
(or options therefor) to employees, consultants and directors, pursuant to plans
or agreements approved by the Board of Directors for the primary purpose of
soliciting or retaining their services, or (ii) to or after consummation of a
bona fide, firmly underwritten public offering of shares of Common Stock,
registered under the Act pursuant to a registration statement on Form S-1 at an
offering price of at least $6.46 per share (appropriately adjusted for any stock
split, dividend, combination or other recapitalization) and not less than
$15,000,000 in the aggregate, or (iii) to the issuance of securities pursuant to
the conversion or exercise of convertible or exercisable securities, or (iv) to
the issuance or sale of the Series A Preferred Stock, or (v) to the issuance of
securities that, with unanimous approval of the Board of Directors of the
Company, are not offered to any existing shareholder of the Company or (vi) the
issuance by the Company of up to 92,879 shares of Common Stock at the per share
price of not less than $3.23.

         3.    Repurchase.
               ----------

               3.1   Repurchase Request. At any time after September 27, 2002
                     ------------------
and provided that the Series A Preferred issued to the holders pursuant to the
Purchase Agreement was not automatically converted into Common Stock pursuant to
Article III(4)(b) of the Company's Articles of Incorporation, but within thirty
(30) days (the "Repurchase Date")after the receipt by the Company of a written
                ---------------
request (the "Repurchase Request") from the Holders of not less than a majority
              ------------------
of the Registrable Securities that all or some of such Holders' shares of
capital stock of the Company be repurchased, and concurrently with surrender by
such Holders of the certificates representing such shares, the Company shall, to
the extent it may lawfully do so, repurchase the shares specified in the
Repurchase Request by paying in cash therefor a sum per share equal to the
higher of (i) $3.23 per share of Series A Preferred Stock (as adjusted for any
stock dividends, combinations or splits with respect to such shares) plus all
declared or accumulated but unpaid dividends on such shares or (ii) the Fair
Market Value (as defined below) of each such share (the "Repurchase Price").
                                                         ----------------
Notwithstanding the foregoing, the Company may, at its option, repurchase the
shares with respect to which the Repurchase Request has been made through the
issuance of one or more promissory notes, each of which shall be secured by all
of the assets of the Company and accrue interest at the prime rate on the
Repurchase Date as reported in the Wall Street Journal, compounded monthly. The
accrued principal and interest under such promissory notes shall be due and
payable in equal quarterly installments over a three year period and may be
prepaid in full by the Company prior to the expiration of such period. The
Repurchase Date shall occur no more than thirty days after the receipt by the
Company of the Repurchase Request, provided that if the last day of such thirty
day period falls on a Saturday, Sunday or legal holiday the Repurchase Date that
would otherwise have occurred on such Saturday, Sunday or legal holiday shall
occur on the next succeeding business day.

               3.2   Notice. At least fifteen (15) but no more than thirty (30)
                     ------
days prior to the Repurchase Date, written notice shall be mailed, first class
postage prepaid, to each Holder of record (at the close of business on the
business day next preceding the day on which notice is given) of the shares of
capital stock to be repurchased, at the address last shown on the records of the
Company for such Holder, notifying such Holder of the repurchase to be effected,
specifying the number of shares to be repurchased from such Holder, the
Repurchase Date, the Repurchase

                                      -15-

<PAGE>

Price, the place at which payment may be obtained and calling upon such Holder
to surrender to the Company, in the manner and at the place designated, his, her
or its certificate or certificates representing the shares to be repurchased
(the "Repurchase Notice"). Except as provided in subsection 3.3 below on or
      -----------------
after the Repurchase Date, each Holder of shares of capital stock to be
repurchased shall surrender to the Company the certificate or certificates
representing such shares, in the manner and at the place designated in the
Repurchase Notice, and thereupon the Repurchase Price of such shares shall be
payable to the order of the person whose name appears on such certificate or
certificates as the owner thereof and each surrendered certificate shall be
canceled. In the event less than all the shares represented by any such
certificate are repurchased, a new certificate shall be issued representing the
unrepurchased shares.

                    3.3 Availability of Funds. From and after the Repurchase
                        ---------------------
Date, unless there shall have been a default in payment of the Repurchase Price,
all rights of the Holders of shares of capital stock designated for repurchase
in the Repurchase Notice as Holders of capital stock (except the right to
receive the Repurchase Price without interest upon surrender of their
certificate or certificates) shall cease with respect to such shares, and such
shares shall not thereafter be transferred on the books of the Company or be
deemed to be outstanding for any purpose whatsoever. If the funds of the Company
legally available for repurchase of shares of capital stock on the Repurchase
Date are insufficient to repurchase the total number of shares of capital stock
to be repurchased on such date, those funds which are legally available will be
used to repurchase the maximum possible number of such shares ratably among the
Holders of such shares to be repurchased based upon their holdings of capital
stock. The shares of capital stock not repurchased shall remain outstanding and
entitled to all the rights and preferences provided herein. At any time
thereafter when additional funds of the Company are legally available for the
repurchase of shares of capital stock, such funds will immediately be used to
repurchase the balance of the shares which the Company has become obliged (but
for lack of legally-available funds) to repurchase on the Repurchase Date and
which it has not repurchased.

                    3.4 Fair Market Value. For purposes of this subsection 3,
                        -----------------
the term "Fair Market Value" shall mean the fair market value determined jointly
by the Company and the Holders of a majority of the shares of capital stock. If
the Company and the Holders cannot agree on the fair market value, then such
value shall be determined by a three member panel, one of which shall be
selected by the Company, one of which shall be selected by Holders of a majority
of the shares of capital stock, and the third of which shall be designated by
the foregoing two members. If such panel cannot agree on the fair market value,
then such value shall be determined by the member of the panel designated by the
other two members.

                    3.5 Conflicts with Articles. The rights set forth in this
                        -----------------------
Section 3 are in addition to any rights set forth in Article III, Section (B) 3
of the Company's Restated Articles of Incorporation (the "Redemption
Provisions"). In the event of any conflict between the rights set forth in the
Redemption Provisions and the terms of this Section 3 the terms of the
Redemption Provisions shall govern.

                                      -16-

<PAGE>

               4    Covenants of the Investors
                    --------------------------

                    4.1 Company Right of First Offer. Subject to the terms and
                        ----------------------------
conditions specified in this Section 4.1, each Investor hereby grants to the
Company a right of first offer with respect to future sales by the Company of
the shares of the Company's Series A Preferred Stock purchased by such Investor
pursuant to the Purchase Agreement ("Series A Preferred Shares")

                    Each time an Investor offers any Series A Preferred Shares,
the Investor shall first make an offering of such Series A Preferred Shares to
the Company in accordance with the following provisions:

                    (a) The Company shall deliver a notice by certified mail
("Series A Notice") to the Company stating (i) its bona fide intention to offer
  ---------------
such Series A Preferred Shares, (ii) the number of such Series A Preferred
Shares to be offered, and (iii) the price and terms, if any, upon which it
proposes to offer such Series A Preferred Shares.

                    (b) Within 15 calendar days after delivery of the Notice,
the Company may elect to purchase or obtain, at the price and on the terms
specified in the Notice, all, but not part, of the Series A Preferred Shares
specified in the Series A Notice.

                    (c) The Investor may, following the expiration of the period
provided in subsection 4.l(b) hereof, offer the remaining unsubscribed portion
of the Series A Preferred Shares to any person or persons at a price not less
than, and upon terms no more favorable to the offeree than those specified in
the Notice.

                    (d) The right of first offer in this paragraph 4.1 shall not
be applicable (i) to or after the Company's consummation of the initial public
offering of its equity securities, or (ii) to an Investor's transfer or
distribution of the Series A Preferred Shares to its partners or affiliates. In
connection with a transfer by an Investor to its partners or affiliates, such
Investor will undertake reasonable efforts to cause such transferee to be bound
by this Section 4.1.

                    4.2 Covenant bv Summit Partners.
                        ---------------------------

                    (a) Summit Ventures IV, L.P. and Summit Investors III, L.P.
(together, the "Summit Entities") each hereby agrees that it shall not sell any
shares of Series A Preferred to a competitor of the Company without the prior
written consent of the Company, which consent shall not be unreasonably
withheld. For purposes of this Section 4.2, a "competitor" of the Company shall
be deemed to mean any person or organization, business or other entity that
directly engages in, or controls, is controlled by or under common control with
such, person, organization, business or other entity which directly engages in,
the development or sale of software products or software services and software
consulting to the oncology market.

                                      -17-

<PAGE>

                         (b) This Section 4.2 shall cease to have further force
or effect after the Company's consummation of the initial public offering of its
equity securities

                  5.     Miscellaneous.
                         -------------

                         5.1 Successors and Assigns. Except as otherwise
                             ----------------------
provided herein, the terms and conditions of this Agreement shall inure to the
benefit of and be binding upon the respective successors and assigns of the
parties (including transferees of any of the Series A Preferred Stock or any
Common Stock issued upon conversion thereof). Nothing in this Agreement, express
or implied, is intended to confer upon any party other than the parties hereto
or their respective successors and assigns any rights, remedies, obligations, or
liabilities under or by reason of this Agreement, except as expressly provided
in this Agreement.

                         5.2 Governing Law. This Agreement and all acts and
                             -------------
transactions pursuant hereto shall be governed, construed and interpreted in
accordance with the laws of the State of California, without giving effect to
principles of conflicts of laws.

                         5.3 Counterparts. This Agreement may be executed in two
                             ------------
or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument.

                         5.4 Titles and Subtitles. The titles and subtitles used
                             --------------------
in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

                         5.5 Notices. Unless otherwise provided, any notice
                             -------
required or permitted by this Agreement shall be in writing and shall be deemed
sufficient upon delivery, when delivered personally or by overnight courier or
sent by telegram or fax, or forty-eight (48) hours after being deposited in the
U.S. mail, as certified or registered mail, with postage prepaid, and addressed
to the party to be notified at such party's address as set forth below or on
Exhibit A hereto or as subsequently modified by written notice.
---------

                         5.6 Amendments and Waivers. Any term of this Agreement
                             ----------------------
may be amended and the observance of any term of this Agreement may be waived
(either generally or in a particular instance and either retroactively or
prospectively), only with the written consent of the Company and the Holders of
a majority of the Registrable Securities then outstanding. Any amendment or
waiver effected in accordance with this paragraph shall be binding upon each
Holder of any Registrable Securities then outstanding, each future Holder of all
such Registrable Securities, and the Company.

                         5.7 Severability. If one or more provisions of this
                             ------------
Agreement are held to be unenforceable under applicable law, the parties agree
to renegotiate such provision in good faith. In the event that the parties
cannot reach a mutually agreeable and enforceable replacement for such
provision, then (x) such provision shall be excluded from this Agreement, (y)
the balance of the Agreement shall be interpreted as if such provision were so
excluded and (Z) the balance of the Agreement shall be enforceable in accordance
with its terms.

                                      -18-

<PAGE>

                         5.8 Aggregation of Stock. All shares of the Preferred
                             --------------------
Stock held or acquired by affiliated entities or persons shall be aggregated
together for the purpose of determining the availability of any rights under
this Agreement.

                            [Signature Page Follows]

                                      -19-

<PAGE>

     The parties have executed this Investors' Rights Agreement as of the
date first above written.

                                    COMPANY:

                                    IMPAC MEDICAL SYSTEMS, INC.

                                    By: /s/ Joseph K. Jachinowski
                                        ---------------------------------
                                        Joseph K. Jachinowski
                                        President

                                    Address: 215 Castro Street
                                             Mountain View, CA 94041

                  SIGNATURE PAGE TO INVESTORS' RIGHTS AGREEMENT

<PAGE>

                                INVESTORS:

                                WA&H INVESTMENT, L.L.C.
                                By: Wessels, Arnold & Henderson Group, L.L.C.
                                    its managing member

                                By: /s/ Kenneth J. Wessels
                                    ____________________________________________
                                    Name:  Kenneth J. Wessels
                                           _____________________________________
                                    Title: Managing Director - CEO
                                           _____________________________________

                                Address: 901 Marquette Avenue
                                         Minneapolis, MN 55402-3280

                                SUMMIT VENTURES IV, L.P.
                                By: Summit Partners IV, L.P., General Partner
                                By: Stamps, Woodsum & Co., IV, General Partner

                                By: /s/ Gregory M. Avis
                                    -------------------------------------------
                                    Gregory M. Avis
                                    Managing Partner

                                Address: 499 Hamilton Avenue, Suite 200
                                         Palo Alto, CA 94301

                                SUMMIT INVESTORS III, L.P.

                                By: /s/ Gregory M. Avis
                                    --------------------------------------------
                                    Gregory M. Avis
                                    Managing Partner

                                Address: 499 Hamilton Avenue, Suite 200
                                         Palo Alto, CA 94301

                 SIGNATURE PAGE TO INVESTORS' RIGHTS AGREEMENT

<PAGE>

                                    EXHIBIT A
                                    ---------

                                    INVESTORS
                                    ---------

          Name/Address                         No. of Shares
          ------------                         -------------

      WA&H Investments, L.L.C.                        23,220
      901 Marquette Avenue
      Minneapolis, MN 55402-3280
      ------------------------------------------------------
      Summit Ventures IV, L.P.                     1,154,412
      499 Hamilton Avenue, Suite 200
      Palo Alto, CA 94301
      ------------------------------------------------------
      Summit Investors III, L.P.                      60,758
      499 Hamilton Avenue, Suite 200
      Palo Alto, CA 94301                          ---------
              Total:                               1,238,390

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00040-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00040-of-00352.parquet"}]]